Scalper1 News
Biotech stocks were selling off hard Friday, and consensus on Wall Street seemed to pin the blame on a letter sent by several House Democrats to Gilead Sciences (GILD) asking for a briefing on the price of its hepatitis C blockbuster Sovaldi. The letter, signed by Reps. Henry Waxman, Frank Pallone and Diana DeGete and dated Thursday, expressed concern that “a treatment will not cure patients if they cannot afford it.” Due to Sovaldi’s $84,000 Scalper1 News
Scalper1 News